Musclepharm's $17.1M sales backlog definitley backs the growth story. Not only was there $17.1M in revenue not-yet realized (granted it wasn't all from Q4), but it's also missed opportunity. If a store orders more protein when they're low, then run out. Until product is stocked up again this store can't sell anymore of this product even to those customer's who came in specifically for it. It's currently hindering growth and management is to blame. $17.1M is rediculous! I get switching to 1 manufacturer, new product launches, etc., but to me letting it get out of control to that high shows mismanagement.